Hypercoagulable state, pathophysiology, classification and epidemiology (Q37809540)

23 August 2017

title

Hypercoagulable state, pathophysiology, classification and epidemiology (English)

1 reference

23 August 2017

1 reference

Zrinka Alfirević

1

1 reference

23 August 2017

Igor Alfirević

series ordinal

2

1 reference

23 August 2017

publication date

16 November 2010

1 reference

Clinical Chemistry and Laboratory Medicine

23 August 2017

published in

1 reference

23 August 2017

volume

48 Suppl 1

1 reference

23 August 2017

page(s)

S15-26

1 reference

Hypercoagulable state testing and malignancy screening following venous thromboembolic events

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Thrombus formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

What does it take to make the perfect clot?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Endothelium: interface between coagulation and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Pathophysiology of venous thrombosis and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

21 January 2018

Inherited thrombophilias

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Genetic susceptibility to venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

21 January 2018

Hereditary thrombophilia

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

X-linked thrombophilia with a mutant factor IX (factor IX Padua).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Thrombophilia and hypercoagulability

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Hypercoagulability syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Common risk factors for both arterial and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Hypercoagulable states in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

The lupus anticoagulant/antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Overview of the main outcomes in breast-cancer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Genetics of thrombophilia: impact on atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Thrombotic risk factors: basic pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

An association between atherosclerosis and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23,796 consecutive autopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Cardiovascular risk factors and venous thromboembolism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Venous thromboembolism and atherothrombosis: an integrated approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Venous thrombosis: a multicausal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Inherited thrombophilia in arterial disease: a selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

World distribution of factor V Leiden

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Protein C and antithrombin deficiency are important risk factors for deep vein thrombosis in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Genetic risk factors of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Antiphospholipid syndrome and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Overview of venous thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2010.371

21 January 2018

Identifiers

DOI

10.1515/CCLM.2010.371

1 reference

23 August 2017

1 reference